Tada Group's COO Leads Successful Usability Testing for ReLink Device in Linköping

Feb 1, 2024

Business focus magazine features Interlinked's transformative journey

Jan 19, 2024

Gratitude for Recognition: Reflecting on Our Entrepreneurial Journey

Jan 17, 2024

Celebrating Milestones: Commencing Our Clinical Trial Journey

Dec 21, 2023

Reflections on a Transformative Journey: Insights from Our Trip to India

Dec 8, 2023

Completion of ReLink Randomized Controlled Trial: A Milestone in Healthcare Innovation

Dec 8, 2023

Expanding Our Reach: ReLink Patent Approved in Brazil!

Dec 6, 2023

Empowering Healthcare Innovation: Reflecting on Our Journey at HTC

Nov 28, 2023

Tada Group Participates in HTC Competition: "Solving X"

Nov 24, 2023

An exhibitor and a returning keynote speaker at ICITAIEE

Nov 23, 2023

LSX Investival Showcase, London!

Nov 20, 2023

Reflecting on an impactful week at MEDICA 2023 in Düsseldorf, Germany.

Nov 17, 2023

Latest patent: This time it is India

Nov 9, 2023

Clinical studies at Parc Sanitari Sant Joan de Deu (PSSJD), Spain

Nov 1, 2023

Networking at Swecare 2023

Oct 25, 2023

Med-Tech World 2023

Oct 24, 2023

Gratitude for Uppsala Life: A Step Towards a Sustainable Future

Oct 19, 2023

Insights and connections from the Association for Vascular Access's annual scientific meeting

Oct 17, 2023

We're Health Tech Challengers Finalists!

Oct 10, 2023

Official logo of Tada Group & upgraded website

Oct 6, 2023

The Startup Club - Health Tech Investment Conference

Sep 26, 2023

Reflecting on LSI Europe '23 Emerging Medtech Summit

Sep 21, 2023

ReLink/LinkUS has entered U.S. clinical trials.

Sep 14, 2023

Proud Moment for Tada Group AB: Patent Approval in Mexico

Aug 31, 2023